The role of dopamine in sleep regulation and in mediating the effects of wa
ke-promoting therapeutics is controversial. In this study, polygraphic reco
rdings and caudate microdialysate dopamine measurements in narcoleptic dogs
revealed that the wake-promoting antinarcoleptic compounds modafinil and a
mphetamine increase extracellular dopamine in a hypocretin receptor 2-indep
endent manner. In mice, deletion of the dopamine transporter (DAT) gene red
uced non-rapid eye movement sleep time and increased wakefulness consolidat
ion independently from locomotor effects. DAT knock-out mice were also unre
sponsive to the normally robust wake-promoting action of modafinil, methamp
hetamine, and the selective DAT blocker GBR12909 but were hypersensitive to
the wake-promoting effects of caffeine. Thus, dopamine transporters play a
n important role in sleep regulation and are necessary for the specific wak
e-promoting action of amphetamines and modafinil.